Ventripoint Diagnostics Stock Forecast

Sell candidate since Jun 09, 2026 Loss -1.39%

The VentriPoint Diagnostics Ltd. stock price gained 0.129% on the last trading day (Monday, 22nd Jun 2026), rising from $0.0850 to $0.0851. It has now gained 5 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 9.13% from a day low at $0.0797 to a day high of $0.0870. The price has risen in 6 of the last 10 days but is still down by -12% for this period. Volume fell on the last day by -254 thousand shares and in total, 25 thousand shares were bought and sold for approximately $2.15 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.0819 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 12.53% during the next 3 months and, with a 90% probability hold a price between $0.0922 and $0.155 at the end of this 3-month period.

VPTDF Signals & Forecast

There are few to no technical positive signals at the moment. The VentriPoint Diagnostics Ltd. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.0988. On a fall, the stock will find some support from the short-term average at $0.0839. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Friday, May 01, 2026, and so far it has fallen -34.34%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for VentriPoint Diagnostics Ltd. stock

VentriPoint Diagnostics Ltd. finds support from accumulated volume at $0.0850 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0073 between high and low, or 9.13%. For the last week the stock has had daily average volatility of 6.16%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (VPTDF) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect VentriPoint Diagnostics Ltd. to open at $0.0839, and during the day (based on 14 day Average True Range), to move between $0.0816 and $0.0886, which gives a possible trading interval of +/-$0.0070 (+/-8.52%) up or down from last closing price. If VentriPoint Diagnostics Ltd. takes out the full calculated possible swing range there will be an estimated 8.52% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.0850 (0.13%) than the resistance at $0.0860 (1.06%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is VentriPoint Diagnostics Ltd. stock A Buy?

The VentriPoint Diagnostics Ltd. stock holds several negative signals and despite the positive trend, we believe VentriPoint Diagnostics Ltd. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -4.382 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $0.0839 ( 1.36%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk